View Product
> Fingertip textured
> Powder Free
> Not made with natural rubber latex
> Chemo drugs tested
> UL certified to meet NFPA 1999
> Ambidextrous
> Extended cuff
> Orange colour
Longer in cuff length, GloveOn Vigor LC is designed for robustness and hardiness to get the tough jobs done. The vibrant choice of orange highlights its uniqueness and suitability for industrial and hospitality markets.
| Reorder Code | Size |
|---|---|
| VGR611SS | Small |
| VGR611MM | Medium |
| VGR611LL | Large |
| NTR27XL | X-Large |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥280 |
| Thickness at Palm (centre of Palm) | 0.13 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.17 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 100 gloves per box 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 164563 FDA 510(k) MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EU 2016/425 |
| International Standards | |
|---|---|
| Standards | ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN ISO 374-1 (Type B) EN 16523-1 EN 374 part 2, 4 & 5 EN 420 EN 455 part 1, 2, 3, 4 ISO 10993 part 5 & 10 ISO 11193-1 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 118903) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 45.4 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 30.9 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Vigor LC nitrile glove at 45.4 minutes and 30.9 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
